Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
Marra M, Santini D, Meo G, Vincenzi B, Zappavigna S, Baldi A, Rosolowski M, Tonini G, Loeffler M, Lupu R, Addeo SR, Abbruzzese A, Budillon A, Caraglia M.
Marra M, et al. Among authors: caraglia m.
Int J Cancer. 2009 Nov 1;125(9):2004-13. doi: 10.1002/ijc.24648.
Int J Cancer. 2009.
PMID: 19530242